Literature DB >> 14736806

Are we overlooking the side effects of the drugs in our zeal to conquer ARMD?

U Bhatt.   

Abstract

Mesh:

Substances:

Year:  2004        PMID: 14736806      PMCID: PMC1772010     

Source DB:  PubMed          Journal:  Br J Ophthalmol        ISSN: 0007-1161            Impact factor:   4.638


× No keyword cloud information.
  5 in total

1.  Intravitreal triamcinolone acetonide in exudative age-related macular degeneration.

Authors:  R P Danis; T A Ciulla; L M Pratt; W Anliker
Journal:  Retina       Date:  2000       Impact factor: 4.256

2.  Intravitreal triamcinolone in subfoveal recurrence of choroidal neovascularisation after laser treatment in macular degeneration.

Authors:  N T Ranson; R P Danis; T A Ciulla; L Pratt
Journal:  Br J Ophthalmol       Date:  2002-05       Impact factor: 4.638

3.  Intraocular pressure after intravitreal injection of triamcinolone acetonide.

Authors:  J B Jonas; I Kreissig; R Degenring
Journal:  Br J Ophthalmol       Date:  2003-01       Impact factor: 4.638

4.  Exudative macular degeneration and intravitreal triamcinolone. A pilot study.

Authors:  P L Penfold; J F Gyory; A B Hunyor; F A Billson
Journal:  Aust N Z J Ophthalmol       Date:  1995-11

5.  Exudative macular degeneration and intravitreal triamcinolone: 18 month follow up.

Authors:  J K Challa; M C Gillies; P L Penfold; J F Gyory; A B Hunyor; F A Billson
Journal:  Aust N Z J Ophthalmol       Date:  1998-11
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.